CLBT
Income statement / Annual
Last year (2024), Cellebrite DI Ltd.'s total revenue was $401.20 M,
an increase of 23.41% from the previous year.
In 2024, Cellebrite DI Ltd.'s net income was -$283.01 M.
See Cellebrite DI Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$401.20 M |
$325.11 M |
$270.65 M |
$246.25 M |
$194.91 M |
$171.85 M |
| Cost of Revenue |
$62.59 M
|
$53.23 M
|
$50.75 M
|
$42.56 M
|
$37.88 M
|
$35.82 M
|
| Gross Profit |
$338.61 M
|
$271.88 M
|
$219.91 M
|
$203.69 M
|
$157.03 M
|
$136.03 M
|
| Gross Profit Ratio |
0.84
|
0.84
|
0.81
|
0.83
|
0.81
|
0.79
|
| Research and Development Expenses |
$98.42 M
|
$84.39 M
|
$80.62 M
|
$65.54 M
|
$54.38 M
|
$46.57 M
|
| General & Administrative Expenses |
$0.00
|
$43.44 M
|
$40.85 M
|
$47.94 M
|
$29.86 M
|
$28.62 M
|
| Selling & Marketing Expenses |
$0.00
|
$110.81 M
|
$97.39 M
|
$76.39 M
|
$61.31 M
|
$61.61 M
|
| Selling, General & Administrative Expenses |
$183.29 M
|
$154.26 M
|
$138.24 M
|
$124.33 M
|
$91.17 M
|
$90.23 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.27 M
|
$750,000.00
|
| Operating Expenses |
$281.70 M
|
$238.64 M
|
$218.86 M
|
$189.87 M
|
$147.82 M
|
$137.55 M
|
| Cost And Expenses |
-$344.30 M
|
$291.87 M
|
$269.61 M
|
$232.42 M
|
$185.70 M
|
$173.37 M
|
| Interest Income |
-$332.89 M
|
$8.89 M
|
$1.60 M
|
$68.48 M
|
$2.71 M
|
$3.48 M
|
| Interest Expense |
$0.00
|
$141,000.00
|
$119.72 M
|
$564,000.00
|
$1.42 M
|
$352,000.00
|
| Depreciation & Amortization |
$10.61 M
|
$10.01 M
|
$9.19 M
|
$7.01 M
|
$5.88 M
|
$4.08 M
|
| EBITDA |
-$265.38 M |
-$64.80 M |
$10.24 M |
$89.88 M |
$16.95 M |
$2.75 M |
| EBITDA Ratio |
-0.66
|
-0.2
|
0.04
|
0.08
|
0.08
|
0.02
|
| Operating Income Ratio |
0.14
|
0.1
|
0
|
0.06
|
0.05
|
-0.01
|
| Total Other Income/Expenses Net |
-$332.89 M
|
-$108.80 M
|
$119.72 M
|
$68.48 M
|
$2.18 M
|
$2.94 M
|
| Income Before Tax |
-$275.98 M
|
-$75.56 M
|
$120.76 M
|
$82.31 M
|
$11.40 M
|
$1.42 M
|
| Income Before Tax Ratio |
-0.69
|
-0.23
|
0.45
|
0.33
|
0.06
|
0.01
|
| Income Tax Expense |
$7.02 M
|
$5.54 M
|
-$45,000.00
|
$10.91 M
|
$5.62 M
|
$3.29 M
|
| Net Income |
-$283.01 M
|
-$81.10 M
|
$120.81 M
|
$71.40 M
|
$5.78 M
|
-$1.88 M
|
| Net Income Ratio |
-0.71
|
-0.25
|
0.45
|
0.29
|
0.03
|
-0.01
|
| EPS |
-1.35 |
-0.43 |
0.64 |
0.5 |
0.0467 |
-0.01 |
| EPS Diluted |
-1.35 |
-0.43 |
0.59 |
0.44 |
0.0467 |
-0.01 |
| Weighted Average Shares Out |
$209.47 M
|
$190.15 M
|
$182.69 M
|
$144.00 M
|
$123.70 M
|
$187.17 M
|
| Weighted Average Shares Out Diluted |
$209.47 M
|
$190.15 M
|
$195.39 M
|
$161.54 M
|
$123.70 M
|
$187.17 M
|
| Link |
|
|
|
|
|
|
